EUVIMEDEUVIMED entdecken
Crossref

Microglial heterogeneity in amyotrophic lateral sclerosis

Kazuya Takahashi iD

Journal of Neuropathology & Experimental Neurology · 2023

DOI: 10.1093/jnen/nlac110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2023. Verfasst von Kazuya Takahashi. Beteiligte Einrichtung: Department of Medicine, National Hospital Organization Iou National Hospital, Kanazawa, Japan. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is an intractable neurodegenerative disease of the central nervous system that is pathologically characterized by motor neuron loss. Although the cause of the disease is still unknown, its pathophysiology is considered heterogeneous. In recent years, there have been a series of reports on the existence of disease-associated microglia (DAM) in the lesions of various neurodegenerative diseases. DAM have also been reported in SOD1-deficient mice, a disease model of ALS. However, the role of DAM in sporadic ALS remains unclear. This study revealed that spinal cord lesions in ALS can be pathologically distinguished into 2 subgroups (TMEM119+ and TMEM119− microglia) according to the type of microglia. Expression of the microglial activation marker CD68 and endothelial activation were also observed in the TMEM119+ microglia group, suggesting the presence of inflammatory processes in ALS lesions. Since DAM suppress the expression of TMEM119, the TMEM119+ microglia group may indicate DAM-independent inflammatory neurodegeneration. These results may explain why, in some clinical trials of anti-inflammatory drugs for ALS, only some cases showed suppression of disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisNeurodegenerative DiseasesMiceAnimalsMicrogliaMice, TransgenicMotor NeuronsSpinal CordDisease Models, AnimalSuperoxide Dismutase-1

Stichwörter der Autor:innen

Amyotrophic lateral sclerosisDAMInflammationMicrogliaTMEM119

Substanzen

Superoxide Dismutase-1

Autor:innen und Institutionen

  • Department of Medicine, National Hospital Organization Iou National Hospital, Kanazawa, Japan.

ORCID-Profile: Kazuya Takahashi

Zitieren

APA

Takahashi, K. (2023). Microglial heterogeneity in amyotrophic lateral sclerosis. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlac110

Vancouver

Takahashi K. Microglial heterogeneity in amyotrophic lateral sclerosis. Journal of Neuropathology & Experimental Neurology. 2023. doi:10.1093/jnen/nlac110

BibTeX
@article{Takahashi2023,
  author = {Takahashi, Kazuya},
  title = {Microglial heterogeneity in amyotrophic lateral sclerosis},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2023},
  doi = {10.1093/jnen/nlac110}
}
Kostenlos starten →